Professional Documents
Culture Documents
Abstract
Background: Treatment of retained products of conception (RPOC) can be expectant, medical or operative.
Surgical removal of RPOC may lead to intrauterine adhesions (IUA) and Asherman’s syndrome.
Objective: To evaluate how treatment options for RPOC affect future fertility by means of a systematic review.
Search strategy: MEDLINE, EMBASE, The Cochrane Library, and clinical trial registers were searched, and reference
lists were scanned.
Selection criteria: Randomised controlled trials (RCT) comparing different treatment options for RPOC
(conservative, medical or surgical treatment, including curettage and/or hysteroscopic techniques, with or without
application of anti-adhesion therapy), in women of reproductive age, were eligible for inclusion.
Data collection and analysis: Reviewers independently performed data extraction and quality of evidence
assessment. For dichotomous variables, results were presented as risk ratio (RR) with 95% CI.
Main results: Two studies were included. Nonsignificant differences were observed between the use of an anti-
adhesion barrier gel versus no treatment after operative hysteroscopy in IUAs (RR 0.32, 95% CI 0.04 to 2.80, P value
= 0.30) and clinical pregnancy (RR 2.22, 95% CI 0.67 to 7.42, P value = 0.19), and between hysteroscopic morcellation
versus loop resection in IUAs (RR 0.86, 95% CI 0.06 to 13.12, P value = 0.91).
Conclusion: There is insufficient evidence on how different treatment options for RPOC affect future reproductive
outcomes. Results from ongoing RCTs are needed to guide clinicians towards choosing the best treatment.
Keywords: Retained products of conception, Treatment, Fertility, Reproductive outcome, Systematic review
Introduction definition [3–5]. Others say that RPOC consist of the ges-
Retained products of conception (RPOC) consist of intra- tational sac, the decidua capsularis, chorionic villi or the
uterine tissue that develops after conception and persists embryo itself [6]. Still others argue that RPOC are from
after miscarriage, termination of pregnancy, delivery or placental origin, and thus, that the presence of chorionic
caesarean section [1]. The occurrence of RPOC is not rare; villi in RPOC is necessary [1, 7].
however, the prevalence varies widely (from 0.5 to as The diagnosis of RPOC remains a clinical challenge.
much as 19%) depending on pregnancy duration, preg- The existence of RPOC may be suspected based on clin-
nancy outcome and the successive management [2]. There ical history, with patients having symptoms of vaginal
is no consensus in literature on the type of tissue RPOC bleeding, abdominal or pelvic pain, and/or fever. How-
comprise. Some authors describe RPOC as non-villous ever, RPOC may also be present in asymptomatic pa-
trophoblastic tissue, chorionic villi or foetal membranes, tients [8]. Ultrasound (US) findings such as a thickened
and they state that decidua alone does not fall within the endometrial echo complex or the presence of an endo-
metrial mass with or without detectable vascularity at
* Correspondence: tjalina.hamerlynck@ugent.be colour or power Doppler US are highly suggestive for
1
Women’s Clinic, Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent,
Belgium
RPOC [1]. Still, there is no consensus on the US criteria,
Full list of author information is available at the end of the article and US alone may not be sensitive and/or specific
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Hamerlynck et al. Gynecological Surgery (2018) 15:12 Page 2 of 7
enough to confirm the presence or absence of RPOC [1]. The last two comparisons were not pre-defined in our
In order to avoid unnecessary procedures, diagnostic review protocol. We included these randomised compar-
hysteroscopy may be of additional value to ultrasonog- isons because at present different hysteroscopic tech-
raphy, although this needs further research [9, 10]. niques are available for the treatment of RPOC and
In case expectant management or medical treatment anti-adhesion therapy following surgical treatment of
of RPOC fails, the surgical treatment traditionally con- RPOC may affect subsequent reproductive outcome
sists of dilation and curettage, preferably under US guid- [18]. The findings of our review might be biased if these
ance, using vacuum aspiration and/or a metal curette. two comparisons were omitted.
Nevertheless, operative hysteroscopy is a suitable alter-
native to ‘blind’ curettage in the treatment of RPOC [5, Types of outcome measures
11–16]. These surgical procedures for RPOC, however, Primary outcomes:
expose the uterus to additional trauma, which can cause
intrauterine adhesions (IUAs) and Asherman’s syn- – Live birth rate. Live birth was defined as the
drome, clinically manifested by menstrual abnormalities, complete expulsion or extraction from its mother of
infertility and recurrent pregnancy loss [17]. a product of fertilisation, irrespective of the duration
The objective of the present study was to evaluate how of the pregnancy, which, after such separation,
the different treatment options for RPOC affect future breathes or shows any other evidence of life, such as
fertility. heart beat, umbilical cord pulsation, or definite
movement of voluntary muscles, irrespective of
Methods whether the umbilical cord has been cut or the
We specified the methods in advance and registered the placenta is attached. We count the delivery of
protocol of the review on PROSPERO (CRD42016042444). singleton, twin or multiple pregnancies as one live
We followed the PRISMA guidelines for writing a systematic birth.
review. – Presence of IUAs at second-look hysteroscopy.
Library (Cochrane Central Register of Controlled Trials were resolved by discussion, with involvement of a third
(CENTRAL)). The search strategy included terms relat- review author (J.B.) where necessary.
ing to or describing the disease (retained products of
conception), management or intervention (expectant, Measures of treatment effect
medical or surgical) and outcome (fertility). The search For dichotomous outcomes, we used risk ratios (RR)
terms were adapted for use to each bibliographic database, with 95% confidence intervals (CI).
and a combination of both MeSH/Emtree and free-text
terms was used (Additional file 1: Appendix S1). There Data synthesis
were no language restrictions in the search, but we in- Statistical analysis was performed using the software RE-
cluded only articles in English, French, German, Dutch, VIEW MANAGER 5.3 provided by the Cochrane Col-
Italian and Portuguese, due to restraints in time and cost. laboration [21]. For dichotomous variables, results were
In addition, the reference lists of eligible studies were presented as RR with 95% CI. We aimed to perform stat-
scanned, and clinical trial registers were searched for on- istical pooling if enough studies were retrieved. However,
going and registered trials (World Health Organization in case of clinical diversity or evidence of substantial
(WHO) International Clinical Trials Registry Platform statistical heterogeneity, we provided a narrative synthe-
(ICTRP) search portal (http://apps.who.int/trialsearch/) sis of the findings rather than statistical pooling.
and ClinicalTrials.gov (https://clinicaltrials.gov)).
Results
Data collection and analysis Description of studies
Selection of studies A total of 777 citations were identified from searching
Duplicates of the studies obtained by the search strategy electronic databases and trial registers, of which 185 du-
were removed using specialised software (EndNote X7). plicate citations were removed. The remaining 592 re-
The titles and abstracts of the remaining studies were cords were assessed for eligibility through checking the
screened independently and simultaneously by two review titles and/or abstracts. We excluded 567 records as be-
authors (D.M., H.V.d.V.). The full texts of the potentially ing obviously irrelevant. The eligibility of the remaining
eligible studies were retrieved and independently assessed 25 articles was assessed by reading the full text. We re-
by the same two review team members for compliance trieved six potentially eligible studies, we included two
with the inclusion criteria, and studies eligible for inclu- randomised trials (Additional file 3: Table S1), one was ex-
sion in the review were selected. Any disagreement during cluded (Additional file 4: Table S2) and three studies are
the selection was resolved through discussion or, if re- ongoing (NCT02201732, NTR4923, ChiCTR-INR-16009
quired, by consulting a third and/or fourth review author 074) (Additional file 5: Table S3). The PRISMA flow chart
(T.H., S.W.). for study selection is shown in Fig. 1.
We included two parallel-design RCTs [10, 22]. The
first trial was performed in a tertiary medical care centre
Data extraction and management in Israel [22]. Fifty-two women underwent hysteroscopic
A pre-piloted form (Additional file 2: Appendix S2) was surgery because of suspected RPOC. The mean age was
used by two review authors (T.H., H.V.d.V.) independ- 29.5 years (standard deviation (SD) 5.1 years) in the
ently to extract data from the included studies for as- intervention group and 31.4 years (SD 6.5 years) in the
sessment of study quality and evidence synthesis. control group. The trial did not include women with pri-
Discrepancies were identified and resolved through dis- mary subfertility. After hysteroscopic removal of RPOC,
cussion, with a third and/or fourth author (J.B., S.W.) a viscoelastic gel, composed of polyethylene oxide and
where necessary. When information regarding an essen- carboxymethylcellulose, was applied or not. All patients
tial topic was missing or unclear, contact with the au- received postoperative sequential hormone treatment
thors was attempted. and antibiotics. The outcomes were clinical pregnancy
and presence of IUAs. The second trial was a multicen-
Assessment of risk of bias in included studies tre study from Belgium and the Netherlands [10].
Risk of bias of the included studies was independently Eighty-six women who underwent hysteroscopic surgery
assessed by two authors (T.H., H.V.d.V.) according to the because of RPOC were included. The mean age was
Cochrane risk of bias assessment (random sequence gen- 32 years (SD 6 years) in the hysteroscopic morcellation
eration, allocation concealment, blinding of participants group and 31 years (SD 4 years) in the loop resection
and personnel, blinding of outcome assessment, incom- group. RPOC were removed by hysteroscopic morcella-
plete outcome data, selective outcome reporting and other tion or loop resection. In the resection group, cold loop
potential sources of bias) [20]. Disagreements between the resection was attempted first, whereas the loop was elec-
review authors over the risk of bias in particular studies trically activated in case the RPOC were too adherent to
Hamerlynck et al. Gynecological Surgery (2018) 15:12 Page 4 of 7
monopolar loop resection (ChiCTR-INR-16009074; second- 3. Sadan O, Golan A, Girtler O et al (2004) Role of sonography in the diagnosis
ary outcomes: IUAs and pregnancy rate). of retained products of conception. J Ultrasound Med 23:371–374
4. Pather S, Ford M, Reid R, Sykes P (2005) Postpartum curettage: an audit of
200 cases. Aust New Zeal J Obstet Gynaecol 45:368–371. https://doi.org/10.
Additional files 1111/j.1479-828X.2005.00445.x
5. Dankert T, Vleugels M (2008) Hysteroscopic resection of retained placental tissue : a
feasibility study. Gynecol Surg 5:121–124. https://doi.org/10.1007/s10397-007-0354-x
Additional file 1: Appendix S1. Search strategy for systematic review on 6. Inal MM, Yildirim Y, Ertopcu K, Ozelmas I (2006) The predictors of retained
fertility outcome after treatment of retained products of conception. (109 kb) products of conception following first-trimester pregnancy termination with
Additional file 2: Appendix S2. Items of the pilot-tested data manual vacuum aspiration. Eur J Contracept Reprod Heal Care 11:98–103.
extraction form. (DOCX 52 kb) https://doi.org/10.1080/13625180500456742
Additional file 3: Table S1. Characteristics of included studies. 7. Kitahara T, Sato Y, Kakui K et al (2011) Management of retained products of
(DOCX 133 kb) conception with marked vascularity. J Obstet Gynaecol Res 37:458–464.
https://doi.org/10.1111/j.1447-0756.2010.01363.x
Additional file 4: Table S2. Characteristics of excluded studies. 8. van den Bosch T, Daemen A, Van Schoubroeck D et al (2008) Occurrence
(DOCX 45 kb) and outcome of residual trophoblastic tissue: a prospective study. J
Additional file 5: Table S3. Characteristics of ongoing studies. Ultrasound Med 27:357–361
(DOCX 100 kb) 9. Vitner D, Filmer S, Goldstein I et al (2013) A comparison between ultrasonography
Additional file 6: Table S4. Risk of bias table. (DOCX 89 kb) and hysteroscopy in the diagnosis of uterine pathology. Eur J Obstet Gynecol
Reprod Biol 171:143–145. https://doi.org/10.1016/j.ejogrb.2013.08.024
10. Hamerlynck TWO, van Vliet HAAM, Beerens AS et al (2016) Hysteroscopic
Abbreviations morcellation versus loop resection for removal of placental remnants: a
ICTRP: International Clinical Trials Registry Platform; IUA: Intrauterine randomized trial. J Minim Invasive Gynecol 23:1172–1180. https://doi.org/10.
adhesion; RCT: Randomised controlled trial; RPOC: Retained products of 1016/j.jmig.2016.08.828
conception; RR: Risk ratio; SD: Standard deviation; US: Ultrasound; 11. Goldenberg M, Schiff E, Achiron R, Lipitz S, Mashiach S (1997) Managing residual
WHO: World Health Organization trophoblastic tissue: hysteroscopy for directing curettage. J Reprod Med 42:26–28
12. Cohen SB, Kalter-Ferber A, Weisz BS et al (2001) Hysteroscopy may be the
Acknowledgements method of choice for management of residual trophoblastic tissue. J Am
We thank Mrs. De Sutter, reference librarian KCGG of the Ghent University, Assoc Gynecol Laparosc 8:199–202
for her assistance with the search strategy. 13. Faivre E, Deffieux X, Mrazguia C et al (2009) Hysteroscopic management of
residual trophoblastic tissue and reproductive outcome: a pilot study. J
Capsule Minim Invasive Gynecol 16:487–490.
There is insufficient evidence on how different treatments for retained https://doi.org/10.1016/j.jmig.2009.04.011
products of conception affect future fertility. 14. Nicopoullos JDM, Treharne A, Raza A, Richardson R (2010) The use of a
hysteroscopic resectoscope for repeat evacuation of retained products of
Authors’ contributions conception procedures: a case series. Gynecol Surg 7:163–166
TH took the lead in writing the manuscript. TH, DM, HVdV and SW 15. Golan A, Dishi M, Shalev A et al (2011) Operative hysteroscopy to remove
contributed to the conception and design, as well as the acquisition of data. retained products of conception: novel treatment of an old problem. J
TH, DM, HVdV, JB and SW contributed to the analysis and interpretation of Minim Invasive Gynecol 18:100–103.
data, drafting, revising and final approval of the review. https://doi.org/10.1016/j.jmig.2010.09.001
16. Rein DT, Schmidt T, Hess AP et al (2011) Hysteroscopic management of
residual trophoblastic tissue is superior to ultrasound-guided curettage. J
Ethics approval and consent to participate
Minim Invasive Gynecol 18:774–778.
Not applicable.
https://doi.org/10.1016/j.jmig.2011.08.003
17. Yu D, Wong YM, Cheong Y et al (2008) Asherman syndrome-one century
Consent for publication later. Fertil Steril 89:759–779. https://doi.org/10.1016/j.fertnstert.2008.02.096
Not applicable. 18. Bosteels J, Weyers S, Kasius J et al (2015) Anti-adhesion therapy following
operative hysteroscopy for treatment of female subfertility. Cochrane Database
Competing interests Syst Rev 11:CD011110. https://doi.org/10.1002/14651858.CD011110.pub2
T.H. received a Clinical PhD Fellowship grant from the Research Foundation– 19. Zegers-Hochschild F, Adamson GD, de Mouzon J et al (2009) International
Flanders (FWO). Committee for Monitoring Assisted Reproductive Technology (ICMART) and
the World Health Organization (WHO) revised glossary of ART terminology,
2009*. Fertil Steril 92:1520–1524.
Publisher’s Note https://doi.org/10.1016/j.fertnstert.2009.09.009
Springer Nature remains neutral with regard to jurisdictional claims in
20. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews
published maps and institutional affiliations.
of Interventions Version 5.1.0 [updated March 2011]. The Cochrane
Collaboration, 2011. Available from www.handbook.cochrane.org
Author details
1 21. Review Manager 5 (RevMan 5) [Computer program]. Version 5.3.
Women’s Clinic, Ghent University Hospital, C. Heymanslaan 10, 9000 Ghent,
Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Belgium. 2Faculty of Medicine and Health Sciences, Ghent University, C.
22. Fuchs N, Smorgick N, Ben Ami I et al (2014) Intercoat (Oxiplex/AP gel) for
Heymanslaan 10, 9000 Ghent, Belgium. 3Department of Gynaecology, Imelda
preventing intrauterine adhesions after operative hysteroscopy for
Hospital, Imeldalaan 9, 2820, Bonheiden, Belgium.
suspected retained products of conception: double-blind, prospective,
randomized pilot study. J Minim Invasive Gynecol 21:126–130. https://doi.
Received: 12 February 2018 Accepted: 20 June 2018
org/10.1016/j.jmig.2013.07.019
23. Smorgick N, Barel O, Fuchs N et al (2014) Hysteroscopic management of retained
products of conception: meta-analysis and literature review. Eur J Obstet Gynecol
References Reprod Biol 173:19–22. https://doi.org/10.1016/j.ejogrb.2013.11.020
1. Sellmyer MA, Desser TS, Maturen KE et al (2013) Physiologic, histologic, and 24. Hooker AB, Aydin H, Brölman HAM, Huirne JAF (2016) Long-term
imaging features of retained products of conception. RadioGraphics 33:781–796 complications and reproductive outcome after the management of retained
2. Hamerlynck TWO, Blikkendaal MD, Schoot BC et al (2013) An alternative products of conception : a systematic review. Fertil Steril 105:156–164.
approach for removal of placental remnants : hysteroscopic morcellation. J https://doi.org/10.1016/j.fertnstert.2015.09.021
Minim Invasive Gynecol 20:796–802. https://doi.org/10.1016/j.jmig.2013.04.024